Hematopoietic cell transplant center personnel should follow published guidelines for hospital room design and ventilation (BIII).
531,532 HCT recipients should ideally be placed in protective environment rooms that incorporate the following features:
X12 air exchanges per h. Central or point-of-use high-efficiency particulate air (HEPA) filters with a 99.97% efficiency for removing particles X0.3 mm in diameter (AIII). [532] [533] [534] Correct filtration is particularly critical in HCT centers with ongoing construction and renovation. 535, 536 Filters should be replaced regularly on the basis of the manufacturers' recommendations, and, when there is ongoing construction, filtration efficiency should be monitored frequently to best determine the appropriate time for replacement (AIII). Directed air flow so that air intake occurs at one side of the room and air exhaust occurs at the opposite side (BIII). 531 Consistent positive air pressure differential between the patient's room and the hallway X2.5 Pa (that is, 0.01 inches by water gauge) (BIII). 531, 532 Well-sealed rooms (for example, filling gaps between walls and windows, outlets, floor and ceiling) should always be used for HCT patients to prevent infiltration of air from outside that could allow the entry of spores and hinder the maintenance of proper pressure differential (BIII). 532, 534, 537 Continuous pressure monitoring, especially while rooms are occupied (BIII) . 531, 532 Consideration should be given to using monitoring systems that alarm when the pressure differential between any protective environment room and adjacent hallway or anteroom falls to o2.5 Pa, to alert staff to possible engineering failures (CIII). Self-closing doors to maintain constant pressure differentials (BIII) . 532 To enable the nursing staff to observe the HCT recipient even when doors are closed, windows can be installed in either the door or the wall of the HCT recipient's room (CIII).
532
When there is a shortage of protective environment rooms to accommodate all HCT patients, the allocation of these rooms should be prioritized for those at highest risk of invasive mold infection (for example, expected prolonged neutropenia, receiving treatment for GVHD) (BIII). In that situation, portable, industrial-grade HEPA filters may be used in non-protective environment rooms to accommodate other vulnerable patients, and should be placed centrally in patient rooms so that space is available around all surfaces to allow free air circulation (BIII). Portable HEPA filters have been shown to remove airborne fungal spores 538 and mycobacteria, 539 and have been used as part of a successful strategy to prevent fungal infections during construction. 540 However, whether they are as effective as central or point-of-use HEPA filters in preventing infection has not been studied.
A laminar air flow room contains HEPA-filtered air that moves in a parallel, unidirectional flow (the air enters the room from one wall and exits the room from the opposite wall). 541 Some studies have shown that laminar air flow may protect patients from infection during aspergillosis outbreaks related to hospital construction. 542 However, routine laminar air flow room use for all HCT recipients has not been shown to provide substantial overall survival benefit, and, therefore, laminar air flow systems are not recommended for newly constructed rooms in HCT centers (DII). 531, 532 There are no recommendations regarding the pressure differential between an HCT center and adjoining buildings, but at least one study showed that negative pressure with respect to an adjoining building contributed to an Aspergillus outbreak. 543 HCT center maintenance personnel should prevent birds from nesting near hospital air-intake ducts (AII). 531, 534, 544, 545 HCT centers should have provisions for backup emergency power and redundant airhandling and pressurization systems to maintain a constant number of air exchanges and room pressurization when the central ventilation system is shut off for maintenance and repair (BIII) . 546 In addition, an Infection Control Risk Assessment should be created by infection control personnel and maintenance personnel to develop protocols for the protection of HCT patients at all times from bursts of mold spores that might occur when air-handling systems are restarted after routine maintenance shut downs (BIII).
546
Owing to this risk, air-handling systems should never be shut off in HCT units for energy conservation purposes.
Anterooms for HCT center rooms are optional, except in the case of HCT recipients requiring airborne precautions for certain infections (BIII). Anterooms should be used to ensure appropriate air balance relative to the protective environment and the hallway; an independent exhaust of contaminated air to the outside should be provided, or a HEPA filter should be placed in the exhaust duct if return air is to be recirculated (BIII). 531, 532 If a protective environment airborne infection isolation room with an anteroom is not available, the patient should be placed in a standard airborne infection isolation room, and a portable, industrial-grade HEPA filter should be used to enhance the removal of spores in the room (BIII). 531 
Construction, renovation and building cleaning
Construction and renovation Hospital construction and renovation may result in an increased risk of health-care-associated invasive mold infection, particularly aspergillosis, among HCT recipients. 531, 547, 548 Therefore, persons responsible for HCT center construction or renovation should consult published recommendations regarding environmental controls during construction (AIII). 531, 549 When construction or renovation is undertaken, plans should include intensified mold-control measures. An Infection Control Risk Assessment should be planned before constructing a facility or designing a new facility (AIII). 531, 532, 550 Construction and renovation infection control planning committees should include engineers, architects, housekeeping staff, infection control personnel, the director of the HCT center, the administration, construction project managers and safety officers. Close coordination among these participants will facilitate compliance with infection control measures during construction, renovation and demolition (BIII). 550, 551 Whenever possible, HCT recipients should avoid construction or renovation areas (AIII). 531, 543, 552, 553 Furthermore, HCT center staff should avoid transporting equipment and supplies used by HCT recipients through construction or renovation areas.
During construction or renovation, HCT center staff should take steps to minimize fungal spore counts in patient rooms by adhering to room ventilation recommendations. 549 During outdoor construction and demolition, the intake air should be sealed (BIII), if possible; if not, filters should be checked frequently to verify that they are well seated and replaced when necessary. In addition, to protect HCT patient care areas during fire drills and emergencies, weather stripping should be placed around stairwell doors, or, alternatively, the stairwell air should be filtered to the level of safety of the adjacent hospital air (BIII). False ceilings should be avoided whenever possible (BII) . 547 If use of false ceilings cannot be avoided, the area above the false ceilings should be vacuumed routinely to minimize dust and, therefore, fungal exposure to patients (BIII).
547
A number of measures have been used to minimize the impact of construction on HCT recipients. 554 During hospital construction or renovation, hospitals should construct rigid, dust-proof barriers with airtight seals 531 between patient care and construction or renovation areas to prevent dust from entering patient care areas (BIII) (go to www.ashe.org/ashe/codes/cdc/pdfs/assessment_icra.pdf for more information). These barriers (for example, sealed drywall) should be impermeable to Aspergillus spores. 531, 534, 549, 552, 555 Construction and renovation areas should have negative air pressure relative to HCT patient care areas to ensure that air flows from patient care areas toward construction areas (AII). 543, 549 If impervious barriers cannot be created around the construction area, patients should be moved from the area until renovation is complete and the area has been cleaned appropriately (BIII). HCT centers should direct pedestrian traffic occurring near construction or renovation areas away from patient care areas to limit the opening and closing of doors or other barriers that might cause dust dispersion, entry of contaminated air or tracking of dust into patient areas, 531,556 particularly HCT center patient care areas (BIII). If possible, specific access routes, such as corridors, elevators, entrances, exits, as well as bathrooms, should be dedicated to construction use only. 531 Tacky floor mats should be placed at the threshold of construction areas to minimize tracking of dust. Visible dust and debris tracked out of the construction zone should be vacuum cleaned with HEPA filters in the vacuum exhaust.
554 Construction workers, whose clothing might be contaminated with mold spores, should use the construction elevator and avoid contact with patients, patient care areas, other elevators and non-construction areas (BIII). A portable, industrialgrade HEPA filter should be used between a construction zone and the HCT unit if a large area is under construction and negative pressure differential cannot be guaranteed (AII). 543, 550 Monitoring of air quality during construction may include daily particle counts, environmental air sampling and more frequent measurements of ventilation pressure differentials (CIII). 543, 557 Monitoring of clinical cases of aspergillosis and other invasive mold infections should be performed, with enhanced surveillance of microbiological, pathological and radiological data to identify trends suggesting an environmental mold source (BIII) (see Surveillance section). Routine microbiological air sampling for fungal spores in HCT units is not recommended, as its role has not been established (DIII). 558-560 However, during a suspected outbreak, there may be a role for microbiological air sampling in patient care areas (CIII). If microbiological air sampling is performed as a part of an outbreak investigation, sample volumes of at least 1000 l may achieve a higher degree of sensitivity than smaller samples. 543, 561 Allogeneic HCT recipients should avoid construction areas inside and outside the health-care facility. HCT recipients may benefit from wearing N95 respirators while outside HEPA-filtered areas, especially during periods of health-care facility construction and renovation (CIII). 543, 552, 553 Although they have been used for patient use, there are no commercially available masks, including N95 respirators, which have been tested specifically for efficacy in reducing patient exposure to Aspergillus or other mold in hospital construction or renovation areas. Standard surgical masks provide negligible protection against mold spores. Whether or not the addition of mold-active prophylaxis would provide additional protection during periods of heavy construction has not been specifically studied, and therefore no recommendation can be made.
Newly constructed or renovated areas should be cleaned and disinfected before patients are allowed to enter them (AIII).
534 Fungal-contaminated materials that cannot be removed and replaced should be decontaminated with copper-8-quinolinolate after cleaning (BIII). 540, 562 Furthermore, areas above dropped ceilings in rooms located under or adjacent to construction areas should be vacuumed (BIII). In addition, ventilation, direction of air flow and room pressurization should be tested and correctly adjusted before patients are allowed to enter (BIII).
549
Cleaning HCT centers should be cleaned at least daily with special attention to dust control (BIII). Wet dusting should be performed; dusting techniques that aerosolize dust should be avoided (BIII). 531, 563, 564 Many studies show that surface contamination is associated with nosocomial infections, but there is a paucity of data showing that routine surface disinfection reduces the rate of infections. 565 Nonetheless, exhaust vents, window sills and all horizontal surfaces should be cleaned with cloths and mop heads that have been premoistened with an approved hospital disinfectant (BIII). 531, 566 A thorough cleaning during and after any construction activity, including minor renovation projects, is critical (BIII).
Floor surfaces and finishes should be smooth, non-porous and scrubbable (for example, vinyl, linoleum, tile) to minimize dust levels (BIII). 144 Carpeting should not be installed in HCT center hallways outside or inside patient rooms (DIII) because contaminated carpeting has been associated with outbreaks of aspergillosis among HCT recipients.
567,568 HCT recipients should not be exposed to vacuuming that could cause aerosolization of fungal spores (for example, Aspergillus species) (EIII). All vacuum cleaners used in the HCT center should be fitted with HEPA filters. 531, 549 An approved disinfectant 539 should be used daily for environmental disinfection and also when wet vacuuming is performed in the HCT center (BIII). If an HCT center provides care for infants, phenolic disinfectants can be used to clean floors, provided they are diluted according to the product label. Phenolic compounds, however, should not be used to clean basinets or incubators (DIII).
539
Water leaks should be cleaned up and repaired as soon as possible, but within 72 h to prevent mold proliferation in floor and wall coverings, ceiling tiles and cabinetry in and around all HCT patient care areas (BIII). 531, 564, 569 If cleanup and repair are delayed X72 h after water leak, the involved materials should be assumed to contain fungi and handled accordingly (for example, discarded preferably or cleaned). 531 A moisture meter to detect water penetration of walls should be used whenever possible to guide decision making (BIII). For example, if the wall does not have o20% moisture content X72 h after water penetration, the affected portions of the wall should be removed (BIII).
531
Design and selection of furnishings should focus on creating and maintaining a dust-free environment. Upholstery should be smooth, non-porous and easily disinfected to minimize contamination with potential nosocomial pathogens.
570 Finishes (that is, wall coverings, window shades and countertops) used in HCT centers should also be scrubbable, non-porous and easily disinfected to minimize dust accumulation (BIII).
Isolation and barrier precautions
Hematopoietic cell transplant centers should follow published guidelines for hospital isolation practices, including Centers for Disease Control (CDC) guidelines for preventing health-care-associated infections (AIII). 144, 534, 571 However, the efficacy of specific isolation precautions in preventing health-care-associated infections among HCT recipients has not been evaluated. HCT recipients should be placed in single-patient rooms (BIII), if possible. If the availability of single-patient rooms is limited, their use should be prioritized for the most severely immunosuppressed patients (for example, HCT recipients during their initial transplant admission, particularly allogeneic HCT recipients, or patients receiving immunosuppressive therapy for GVHD during readmissions) (BIII).
In general, allogeneic HCT recipients are likely to benefit from protective isolation measures (that is, a protective environment), including HEPA filtration and/or laminar air flow, to reduce exposure to environmental fungi (for example, Aspergillus sp.) and reduce transplant-related mortality (See Ventilation section) (BIII). 144, 572 The efficacy of protective isolation measures for autologous HCT recipients is not well established (BIII), 573 and individual circumstances should guide the prioritization of protective environment rooms in settings in which the number of these rooms is limited (for example, some patients who receive tandem autologous HCT may be more immunosuppressed than those who receive non-myeloablative allogeneic HCT) (BIII).
At a minimum, standard precautions should be followed for all patient contacts (AIII). Standard precautions include maintaining hand hygiene and wearing of appropriate personal protective equipment (for example, gloves, surgical masks or eye and face protection and gowns) during procedures and activities that are likely to generate splashes or sprays of blood, body fluids, secretions or excretions, or cause soiling of clothing.
144 Some centers use additional protective precautions (for example, gloves and mask, either during respiratory season or year round) in an attempt to further reduce the risk of transmission of respiratory viruses from health-care workers (HCWs) and visitors to patients. However, there are insufficient data to provide recommendations regarding the use of additional protective precautions.
When indicated on the basis of coexisting conditions, HCT recipients should also be placed on airborne, droplet or contact precautions, in addition to standard precautions (AIII). 144 Adherence to isolation precautions is critical in preventing transmission of infectious agents among HCT recipients, HCWs and visitors (AIII). HCT recipients with illnesses due to respiratory or gastrointestinal viruses can have prolonged or episodic excretion of organisms (for example, Respiratory syncytial virus (RSV), adenovirus, rotavirus). Guidance regarding the duration of isolation precautions for specific pathogens is provided in the Control of Specific Healthcare-Associated Infections section.
Hematopoietic cell transplant recipients may benefit from wearing masks or N95 respirators during the preengraftment period when they are outside their hospital rooms, especially during periods of hospital construction and renovation (CIII). All HCT recipients who are immunocompromised (phases I-III of immune system recovery) and candidates undergoing conditioning therapy should minimize the time spent in crowded areas to avoid exposure to persons with community-acquired respiratory virus (CRV) infections (BIII).
Hand hygiene
Hand hygiene is the mainstay of infection prevention in a hospital and is an essential element of Standard Precautions for all patients (AII). 144 Hand hygiene includes both the use of alcohol-based hand rubs and hand washing with soap (plain or antimicrobial) and water. HCT center HCWs, whose duties include direct patient contact, should not wear artificial fingernails or extenders because these have been associated with outbreaks of Gram-negative bacillus and candidal infections (EIII).
574-576 HCT center policies should encourage visitors to maintain hand hygiene before and after each patient visit (BIII). HCT recipients and candidates and their household contacts should be educated with regard to the importance of maintaining hand hygiene during HCT hospitalization and after hospital discharge (BIII).
In the absence of visible soiling of hands or contact with spore-forming organisms (see Recommendations regarding Clostridium difficile), the preferred method of maintaining hand hygiene is using an alcohol-based hand rub because of its superior microbicidal activity, reduced drying of the skin and convenience (AII). [577] [578] [579] [580] [581] When hands are visibly dirty or soiled with blood or body fluids, hands should be washed using soap and water (AI). 579 Hand hygiene should be maintained under the following circumstances: 579 Before direct contact with patients. After contact with blood, body fluids or excretions, mucous membranes, non-intact skin or wound dressing. After contact with a patient's skin. When hands will be moving from a contaminated to a clean body site during patient care. After contact with medical equipment or the hospital environment in the immediate vicinity of the patient. If gloves are worn, before donning and after removing them.
Equipment
Equipment and devices should be cleaned, disinfected or sterilized, and maintained as directed by established guidelines (AIII). 532, 534, 539, [582] [583] [584] [585] [586] Opened and unopened wounddressing supplies (for example, adhesive bandages 587,588 and surgical and elastic adhesive tape 589 ) should be examined for factors that, if left unchecked, could result in mold contamination and possible subsequent cutaneous transmission to patients (BII). This should consist of discarding all bandages and wound dressings that are out of date, have damaged packaging or are visually contaminated by construction debris or moisture (BIII). When arm boards are used to provide support for i.v. lines, only sterile dressing materials should be used, 590 and arm boards should be changed frequently (for example, daily) (BIII). In addition, non-sterile tongue depressors inserted into a piece of foam tubing should not be used as splints for i.v. and arterial catheter sites because these have been associated with an outbreak of fatal invasive nosocomial Rhizopus microsporus among preterm (that is, very low birthweight) infants (DII).
591

Plants, play areas and toys
Although exposure to plants and flowers has not conclusively caused invasive mold infections among HCT recipients, most experts recommend that plants and dried or fresh flowers should not be allowed in hospital rooms during conditioning or after HCT (phases I-III of immune system recovery) because Aspergillus species have been isolated from the soil of potted ornamental plants (for example, cacti), from the surface of dried flower arrangements and from fresh flowers (DIII). 533, 534, 547, 592 In addition, high counts of Gram-negative bacteria have been found in vase water of cut flowers, with Pseudomonas most frequently isolated. 531 To minimize the risk of mold infection, HCT recipients and candidates should avoid contact with soil-based materials (for example, clay or potting soil) (DIII).
Toys are commonly colonized with bacteria (for example, Staphylococcus aureus, Enterococcus) and viruses associated with respiratory and gastrointestinal illnesses. [593] [594] [595] [596] There is no evidence to date indicating that toys can serve as a source of mold infection. Water-retaining bath toys should not be used by immunocompromised HCT recipients and candidates, as they have been associated with an outbreak of Pseudomonas aeruginosa in a pediatric oncology ward (DII).
597
Published recommendations for washing and disinfecting toys should be followed (BIII).
598 Cloth or plush toys should be washed in a hot cycle of a washing machine at least once weekly and more often as needed (BIII). Alternatively, machine washing in a cold cycle is acceptable if laundry chemicals for cold water washing are used in proper concentration. 598 Hard plastic toys should be scrubbed with warm soapy water using a brush to clean crevices, rinsed in clean water, immersed in a mild bleach solution that is made fresh daily (see section on bleach disinfection) for 10-20 min, rinsed again and allowed to air dry. 539 Alternatively, hard plastic toys can be washed in a dishwasher or hot cycle of a washing machine (BIII). Broviac dolls (which are used to demonstrate medical procedures (for example, insertion of catheters) to children to lessen their fears) should be disassembled on completion of play and washed and disinfected before other children are allowed to play with them (BIII). 539, 582 Infants, toddlers and children who put toys in their mouths should not share toys (BIII).
598 Toys that cannot be washed or disinfected after use should be avoided (DIII). Occupational and physical therapy items should be cleaned and disinfected as previously described (BIII).
Play areas for pediatric HCT recipients and candidates undergoing conditioning therapy should be cleaned and disinfected daily, or more frequently if needed (BIII). Toys, games and videos should be allowed in playrooms in HCT centers only if they can be kept clean and disinfected (BIII). Toys, games and videos that are provided in an individual patient room should be thoroughly washed before they are brought into the room, and thereafter at least once weekly or more frequently as needed (BIII). 539, 582, 598 Disposable play items should be offered whenever possible to children on contact precautions (BIII). If a child on contact precautions has used a toy, game or video, the item should be thoroughly cleaned and disinfected before being used by other children (BIII). When a child no longer requires contact precautions, any toys, games and videos used during the period of isolation should be thoroughly cleaned and disinfected (BIII). 539, 582, 598 All cloth or plush toys used by a child on contact precautions should be washed in a washing machine before the toy is given to another child or placed in a play area (BIII). Toys that have been used in an isolation room and that cannot be thoroughly disinfected should be discarded (BIII).
Health-care personnel
Hematopoietic cell transplant centers should provide a written comprehensive policy regarding immunizations and vaccinations for HCT center employees that meets current CDC, Advisory Committee on Immunization Practices, as well as Healthcare Infection Control Practices Advisory Committee recommendations (BIII) . 304 Immunization of all HCWs with all recommended vaccines is critical to prevent transmission of vaccine-preventable diseases to HCT recipients and candidates undergoing conditioning therapy. Where an equivalently effective option exists, HCWs caring for HCT recipients should preferentially receive inactivated vaccines (for example, trivalent inactivated influenza vaccine, inactivated polio vaccine) rather than live vaccines to minimize the theoretical risks of transmission of vaccine virus to HCT recipients (see Family members who receive live vaccines section) (AIII).
Every effort should be made to restrict, from direct patient care activities, all HCWs with infections that are potentially transmissible to HCT recipients or candidates (AII). The extent of work restrictions (for example, leave from work vs temporary reassignment to non-patient care duties) will depend on the specific infection. HCWs with draining skin and soft tissue infections, or other skin or mucous membrane lesions (for example, herpes simplex virus lip lesions) that cannot be completely covered, should also be restricted from patient contact (BIII). Published recommendations regarding the duration of work restrictions for HCWs with infectious diseases should be followed (BIII).
599,600 HCT center HCWs with blood-borne viral infections (for example, HIV or hepatitis B or C viruses) should not be restricted from patient contact (DIII). 601, 602 Work exclusion policies should be designed to encourage HCWs to report their illnesses or exposures (AII).
HCT center visitors
Hematopoietic cell transplant centers should have written policies regarding the screening of all visitors for communicable infections (BIII). In some institutions, trained personnel (for example, administrative or nursing personnel) perform active screening at key entry points to HCT units, particularly during the respiratory virus season. At a minimum, signs should be posted to inform the public about visitation restrictions. Ideally, staff should actively screen visitors daily (Appendix 2). Visitors with signs or symptoms suggestive of communicable infections (for example, fever, Upper respiratory infections or flu-like symptoms, diarrhea, vomiting) or recent known exposure to communicable infections (for example, chickenpox, mumps, measles, pertussis) should be excluded from direct contact with HCT recipients or candidates undergoing conditioning therapy (BII).
603 This is particularly important during periods of widespread CRV activity in the surrounding community or suspected nosocomial CRV outbreaks. Staff should request that affected visitors leave the HCT center until signs and symptoms of infection have resolved or, for recent exposures to communicable infections, until the incubation period for that infection has passed without the appearance of signs or symptoms suggestive of active infection (AII). Visitors should also be screened for recent receipt of live vaccines and excluded as appropriate (see Family Members who Receive Live No absolute minimum age requirement for HCT center visitors exists; however, all visitors must be able to follow appropriate hand hygiene and isolation precautions (AIII). The number of HCT center visitors at any one time should be limited to a number that permits the nursing staff to perform appropriate infection screening and adequate instruction and supervision of hand hygiene and glove and mask use, as appropriate (BIII).
Hospitals with nearby family lodging facilities (for example, Ronald McDonald houses) should share information with these facilities regarding practices to prevent the spread of communicable infections within these types of facilities and to health-care facilities (BIII).
Patient skin and oral care
To optimize skin care, HCT recipients should take daily showers or baths using a mild soap during and after transplantation (BIII). For patients with GVHD, regular lubrication of dry, intact skin with emollients may decrease pruritus and maintain skin integrity. 604 Ointments and creams are more effective than lotions and less likely to sting when applied to sensitive skin.
604
A routine inspection of skin sites that are likely to be portals of infection (for example, perineum, intravascular access sites) is recommended during neutropenia (BIII). HCT recipients and candidates undergoing conditioning therapy should maintain good perineal hygiene to minimize loss of skin integrity and risk of infection (BIII). To facilitate this, HCT centers should develop protocols for patient perineal care, including recommendations for a gentle but thorough perineal cleaning after each bowel movement and a thorough drying of the perineum after each episode of urination (BIII). After using the toilet, females should always wipe the perineum from the front to the back to prevent fecal contamination of the urethra and urinary tract infections (AIII). To prevent vaginal irritation and to avoid risk of cervical and vaginal abrasions that can serve as portals of entry for infection, menstruating HCT recipients should not use tampons (DIII). The use of rectal thermometers, enemas or suppositories; internal rectal exams; and sexual practices involving anal penetration are contraindicated among HCT recipients to avoid skin or mucosal breakdown, which can introduce pathogens (DIII).
To reduce the risk of oral and dental infections, all HCT candidates and their caregivers should be educated regarding the importance of maintaining good oral and dental hygiene for at least the first year after HCT (AIII). HCT candidates should be informed that establishment of the best possible periodontal health before HCT is of substantial benefit in avoiding short-and long-term oral infections, and that maintenance of oral hygiene after HCT can minimize the severity of infections and facilitate healing of mucositis, particularly before engraftment (BIII). 200, 605 If time permits, all HCT candidates should undergo a dental evaluation and relevant treatment before the start of conditioning therapy (AIII). 606, 607 Patients with previous exposure to bisphosphonates should be treated according to established guidelines. [608] [609] [610] Prophylaxis against oral mucositis with keratinocyte growth factor-1 (palifermin) can be considered for patients undergoing myeloablative transplantation.
611 Palifermin reduces the incidence, severity and duration of mucositis, and the incidence of febrile neutropenia, and may diminish the risk of bacteremia after autologous HCT.
611 Elective dentistry should be postponed until the patient has shown substantial immune recovery.
607
Patients' dentists should eliminate likely sources of dental infection, for example, by restoring teeth with moderate-tosevere caries and repairing ill-fitting dental prostheses (BIII). 607 Dentists should extract teeth compromised by moderate-to-severe periodontal disease, non-restorable carious teeth and partially impacted teeth. 200, 607 Ideally, at least 10-14 days should elapse between the completion of tissue-invasive oral procedures and onset of conditioning therapy, to enable adequate healing and monitoring for post-surgical complications (AIII).
Hematopoietic cell transplant recipients with mucositis and HCT candidates undergoing conditioning therapy should maintain oral hygiene by performing oral rinses 4-6 times per day with sterile water, normal saline or sodium bicarbonate solutions (AIII).
605 HCT recipients and candidates should brush their teeth 2-3 times per day with a soft regular toothbrush that is replaced regularly.
605,607
If the recipient cannot tolerate this, a foam tooth swab can be used (CIII), although these control plaque and prevent caries less effectively than do toothbrushes, and must be used gently as they can exacerbate mucositis.
607,612 Using toothpaste is optional, depending on the recipient's tolerance (CIII).
607 HCT recipients and candidates undergoing conditioning therapy who are skilled at dental flossing should floss daily if this can be carried out without trauma (BIII). Routine dental supervision to monitor and guide the patient's maintenance of oral and dental hygiene should be provided or encouraged (BIII).
To decrease the risk of mechanical trauma and infection of oral mucosa, HCT patients should not wear fixed orthodontic appliances or space maintainers from the start of conditioning therapy until preengraftment mucositis resolves or during any subsequent periods of mucositis (EIII).
607 Dental and transplant teams and the patient's community dentist should coordinate the removal of these appliances and long-term rehabilitation of any oral lesions (BIII). Patients should minimize the use of removable dentures during conditioning and during the early post transplantation period to reduce the potential for mucosal injury. It is recommended that HCT recipients at risk for mucositis wear dentures only while eating, clean them twice daily with a soft toothbrush and, when not wearing them, soak dentures in an antimicrobial denture soaking solution that is changed daily (BIII).
607
Patients with GVHD of the oral cavity should undergo frequent dental evaluation because of the accelerated pace of dental caries in those patients (BIII).
613 Dental caries, gingivitis and periodontal disease must be managed promptly to avoid infectious sequelae, including periodontitis and dental abscesses. Regular brushing, flossing, rinsing, fluoride treatments and management of xerostomia 615-617 Appropriate tests to confirm LD include culture of sputum, bronchoalveolar lavage and tissue specimens; testing bronchoalveolar lavage specimens for Legionella by direct fluorescent Ab; and testing for Legionella pneumophila serogroup 1 Ag in urine. However, several of the Legionella outbreaks in immunocompromised patients described in the literature were because of species other than L. pneumophila serogroup 1 species, and therefore would not have been detected by the urine Ag assay. [615] [616] [617] Currently, sufficient evidence is lacking to make recommendations regarding Legionella PCR testing.
The incubation period for LD is usually 2-10 days. Thus, laboratory tests confirmed that legionellosis occurs in a patient who has been hospitalized continuously for nosocomial LD.
531,534 When a definite or possible case of laboratory-confirmed nosocomial LD 615,618 is identified in a person who was in the inpatient HCT center during all or part of the 2-10 days before illness onset, or if two or more cases of laboratory-confirmed LD occur among patients who had visited an outpatient HCT center, the case(s) should be reported to the local or state health department if the disease is reportable in that state or country or if assistance is needed (AIII). 531, 534 In addition, in consultation with the hospital infection control team, a thorough epidemiological and environmental investigation should be conducted to determine the likely environmental source(s) of Legionella species (for example, showers, tap water faucets, cooling towers and hot water tanks) (AI). 531, 534 The source of Legionella infection should be identified and decontaminated (AIII). Extensive hospital investigation of an isolated case of possible nosocomial LD might not be indicated if the patient has had limited contact with the inpatient HCT center during most of the incubation period (CIII).
Hematopoietic cell transplant centers should follow published recommendations regarding the prevention of nosocomial legionellosis (BIII).
531,534 HCT center personnel should use only sterile water (that is, not distilled nonsterile water) to fill reservoirs of nebulization devices 534 and to rinse nebulization devices and other semicritical respiratory-care equipment after cleaning or disinfection (BII). HCT centers should not use large-volume room air humidifiers that create aerosols (for example, by Venturi principle, ultrasound or spinning disk) and, thus, are actually nebulizers (DI), 534 unless these humidifiers are sterilized or subjected to daily high-level disinfection and filled with sterile water only (CIII).
534
When a new hospital with an HCT center is constructed, the cooling towers should be placed in such a manner that the tower drift is directed away from the hospital's airintake system, and the cooling towers should be designed so that the volume of aerosol drift is minimized (BII). 534 For operational hospital cooling towers, hospitals should install drift eliminators, regularly use an effective biocide, maintain cooling towers according to the manufacturer's recommendations and keep adequate maintenance records (BII).
Decorative fountains should not be installed in HCT units or in areas in a health-care facility frequented by HCT recipients (BIII). A clonal outbreak of LD linked to a decorative fountain despite efforts to prevent Legionella contamination was recently described. 619 Available data do not suggest that drinking tap water poses a risk for Legionella exposure among HCT recipients in the absence of an outbreak.
As HCT recipients are at a higher risk for disease and death from legionellosis compared with other hospitalized persons, 615 periodic routine culturing for Legionella species in water samples from the HCT center's potable water supply could be included as part of an overall strategy for preventing LD (CIII). 531, 534, 620, 621 However, the optimal methodology (that is, frequency or number of sites) for environmental surveillance cultures in HCT centers has not been determined, and the cost-effectiveness of this strategy has not been evaluated. 531, 534 As a 'safe' concentration of Legionella organisms in potable water has not been established, the goal should be to maintain water systems with no detectable organisms (AIII). 531, 534 If Legionella species are detected in the water being supplied to an HCT center, the following measures should be undertaken until Legionella species are no longer detected by culture: 531, 534 Decontaminate the water supply (AII). Prevent patients from showering with LD-contaminated water. Instead, provide HCT recipients with sponge Guidelines for preventing infections in HCT D Yokoe et al baths using water that is not contaminated with Legionella species (for instance, use water that is not from the HCT center's potable water system) (BIII). Do not use faucets containing LD-contaminated water in patient rooms or the HCT center or ambulatory HCT clinics to avoid creating infectious aerosols (DIII). Provide HCT recipients with sterile water instead of tap water for drinking, brushing teeth or flushing nasogastric tubes during proven or suspected legionellosis outbreaks (BIII).
Recommendations regarding methicillin-resistant S. aureus Hematopoietic cell transplant centers should follow published recommendations to prevent health-careassociated transmission of methicillin-resistant S. aureus (MRSA). 144, [622] [623] [624] [625] To prevent MRSA transmission, adherence to the following infection control practices is recommended: 144, 579, 623, 624 Maintain hand hygeine with either an alcohol-based hand rub or wash hands with soap and water if soiled before and after all patient contact or contact with the patients' potentially contaminated equipment or environment (AII). Use contact precautions for patients colonized or infected with MRSA, including the use of gloves and gowns (AII). Ensure adherence to standard environmental cleaning with an effective disinfectant (BIII). 531, 539 There is insufficient evidence at present to recommend a routine screening of all HCT recipients for MRSA or the use of topical or systemic antimicrobial therapy for patients with asymptomatic MRSA colonization, although these are areas of active research. 626, 627 If high rates of MRSA persist despite implementation of basic infection control practices, HCT centers should consider adjunctive strategies such as implementing a program to obtain MRSA surveillance cultures on admission and serially (for instance, weekly) (BII) 628 with or without decolonization therapy (BIII); 627 routine bathing of patients with chlorhexidine (BIII); 629 cohorting of MRSA patients in designated areas (for example, bays, patient care areas); or by assigning care to dedicated staff (CIII). 624 The potential impact of rapid molecular techniques to identify S. aureus nasal carriage to prevent MRSA transmission is another area of active research, and recommendations regarding use of rapid techniques for MRSA cannot be provided at this time. The emergence of community-associated MRSA infection has further complicated the prevention and control of MRSA. Optimal strategies for prevention of transmission and infection with community-associated MRSA are currently unknown.
The optimal duration of contact precautions for patients with MRSA is unknown, although studies have shown that patients can remain persistently colonized for extended periods of time. Some HCT centers may opt to implement MRSA discontinuation criteria (for example, continue contact precautions until all antimicrobials active against the MRSA isolate are discontinued and three consecutive screening cultures taken on separate days are negative) (CIII).
624
For patients with recurrent MRSA infection, eradication of the carrier state can be attempted by applying a 2% mupirocin calcium ointment to the nares, by the use of topical antiseptics such as chlorhexidine for bathing or by the administration of systemic antimicrobials, although these strategies have not been shown to be consistently effective (Appendix 1) (CII). 630, 631 High-level mupirocinresistant MRSA has been reported in Europe, the Middle East and South America, [632] [633] [634] [635] [636] but is less common in the United States. As with any antimicrobial agent, incorrect use or overuse of mupirocin can result in the emergence of mupirocin-resistant staphylococci; therefore, mupirocin use should be coordinated with the local hospital infection control team. 632, 633 Selection of systemic antimicrobials used to treat MRSA infection should be guided by susceptibility patterns. Recommendations for treatment of MRSA infections are beyond the scope of this guideline; refer to published treatment guidelines.
Recommendations regarding staphylococcus species with reduced susceptibility to vancomycin All HCT centers should have sufficient laboratory capability to identify all Staphylococcus isolates and their antimicrobial susceptibility patterns, including vancomycin susceptibility (AII). [637] [638] [639] In addition, HCT centers should conduct routine surveillance for the emergence of Staphylococcus species strains with reduced susceptibility to vancomycin (AIII). 640, 641 Reduced susceptibility to vancomycin is defined as those S. aureus strains that have a vancomycin minimum inhibitory concentration of X2 mg/ml and those coagulase-negative staphylococci that have a vancomycin minimum inhibitory concentration of X4 mg/ml.
If a patient in an HCT center is colonized or infected with a staphylococcal strain that has reduced susceptibility to vancomycin, infection control personnel should follow published guidelines for the control of such species (BIII). 638, 642, 643 Avoiding overuse and misuse of antimicrobials will decrease the emergence of Staphylococcus species with reduced susceptibility to vancomycin. 641, 642 Therefore, medical and ancillary staff members who are responsible for monitoring antimicrobial use patterns in the facility should routinely review vancomycin use patterns (AII). 638, 642, 643 In addition, HCT center personnel should institute the prudent use of all antimicrobials, including vancomycin, to prevent the emergence of Staphylococcus with reduced susceptibility to vancomycin (AII). 638, 640, [642] [643] [644] [645] Recommendations regarding vancomycin-resistant enterococci Hematopoietic cell transplant recipients frequently have multiple risk factors for vancomycin-resistant enterococci (VRE) colonization and infection, and VRE infection is associated with poor outcomes among HCT recipients.
646,647 A history of resolved VRE bacteremia or known VRE colonization, however, is not a contraindication for HCT (BIII).
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To reduce the risk of VRE infection, HCT clinicians should minimize the use and duration of treatment with vancomycin and antimicrobial agents with antianaerobic coverage (for example, metronidazole and third-generation cephalosporins) (AII). 638, [648] [649] [650] Although both oral vancomycin and metronidazole promote overgrowth of VRE in stool, the risk of acquiring VRE or promoting VRE overgrowth should not be a defining consideration when selecting oral vancomycin for treatment of severe or recurrent C. difficile infection (CDI) (BIII).
650,651
Patients colonized with VRE typically remain colonized for long periods extending beyond the hospitalization during which the initial VRE-positive culture result was obtained.
652,653 VRE may 're-emerge' after earlier negative cultures when the patient is reexposed to antimicrobials. 624, 654 Contact precautions for HCT recipients with past VRE colonization or infection should be continued during hospital readmissions (AIII). Although there are insufficient data to provide recommendations regarding the optimal duration of precautions for HCT recipients with a history of VRE, individual HCT centers can consider implementing criteria for the discontinuation of contact precautions (for example, three consecutive sets of screening cultures negative for VRE obtained on separate days for a patient who is not receiving antimicrobial therapy active against the VRE isolate).
To prevent VRE transmission, the following infection control measures are recommended: 579, 655 Maintain hand hygiene with an alcohol-based hand rub or by washing hands with soap and water if soiled before and after all patient contact or contact with the patients' potentially contaminated equipment or environment (AII). Use contact precautions for patients colonized or infected with VRE, including the use of gloves and gowns (AII). Ensure adherence to standard environmental cleaning with an appropriate disinfectant (BIII).
539
Antimicrobial treatment of VRE carriers has not been adequately studied, and carries potential risks, including toxicity and the development of drug-resistant organisms; therefore, it should be discouraged (DIII). The effectiveness of active surveillance cultures for VRE to prevent healthcare-associated transmission of VRE is unknown. VRE rectal or stool active surveillance cultures to identify colonized patients can be considered if there is evidence for ongoing transmission of VRE in an HCT unit (CIII).
622
Recommendations regarding multidrug-resistant Gram-negative bacilli Multidrug-resistant Gram-negative bacilli (MDR-GNB) are defined as GNB that are resistant to one or more classes of antimicrobial agents, including those producing extended-spectrum b-lactamases and carbapenemases. In addition to Escherichia coli and Klebsiella pneumoniae, MDR-GNB includes highly resistant strains of Acinetobacter baumannii and organisms such as Stenotrophomonas maltophilia, Burkholderia cepacia and Ralstonia pickettii with intrinsically broad antimicrobial resistance. A detailed discussion of MDR-GNB and recommendations for prevention were published in 2006.
624 Judicious use of antimicrobial agents is important for controlling MDR-GNB (BII). Several studies have shown a temporal association between formulary changes and decreased incidence of targeted MDR-GNB.
656
As with other multiple drug-resistant organisms, adherence to the following infection control measures is important to prevent health-care-associated transmission: 144, 579 Maintain hand hygiene with an alcohol-based hand rub or by washing hands with soap and water if soiled before and after all patient contact or contact with the patients' potentially contaminated equipment or environment (AII). Use contact precautions, including gowns and gloves, for patients colonized or infected with MDR-GNB, which are of epidemiological importance for each HCT center (AII). Ensure adherence to standard environmental cleaning with an effective disinfectant (BIII).
531,539
On the basis of current evidence, it is unclear whether the addition of an active surveillance-culturing (ASC) program for MDR-GNB to basic infection control practices is useful. Some studies have reported a successful reduction of extended-spectrum b-lactamase-producing Enterobacteriaceae over a 6-year period using a multifaceted control program that included the use of ASC. 657, 658 Other reports suggest that use of ASC is not necessary to control endemic MDR-GNBs. 659 However, the CDC and the Healthcare Infection Control Practices Advisory Committee now recommend that a single round of surveillance be conducted in high-risk settings (for example, units in which patients are exposed to broad-spectrum antimicrobials), if previously unidentified cases of carbapenem-resistant or carbapenemase-producing Klebsiella spp. or E. coli are identified on a review of microbiology records.
660 Units experiencing high rates of MDR-GNB infection can consider the use of ASC as a component of their control and prevention program (CIII), although there is insufficient information to provide a recommendation regarding the use of ASC to prevent transmission of MDR-GNB.
Recommendations regarding C. difficile Hematopoietic cell transplant centers should follow published recommendations for preventing, controlling and treating CDI (AI). 661, 662 Patients with CDI should be placed on contact precautions for the duration of illness (BIII). 144, 662 All HCWs who have contact with a C. difficileinfected patient or with the patient's environment should don gloves (AI) and gowns (BIII) before entering the patient's room. 144, [661] [662] [663] [664] Contact precautions should be continued at least until the patient is asymptomatic (BIII).
661 A 'test of cure' to determine whether contact precautions can be discontinued is discouraged (DII).
661
If there is evidence of ongoing transmission of C. difficile despite implementation of the basic prevention practices described above, HCT centers should consider maintaining contact precautions even after diarrhea has resolved and Guidelines for preventing infections in HCT D Yokoe et al until hospital discharge (CIII). 665 During nosocomial CDI outbreaks, HCT centers should work closely with their Infection Prevention and Control staff to ensure implementation of appropriate control measures (AIII). The following practices are not recommended for the prevention of C. difficile transmission:
Performing routine stool surveillance cultures or toxin assays for C. difficile among asymptomatic patients or HCWs, even during outbreaks (DIII). Culturing the hand swabs of HCWs for C. difficile (EIII). Treating asymptomatic C. difficile carriers to prevent clinical infection (EII).
666
Hand hygiene compliance may decrease when soap and water is the preferred method. Alcohol-based hand rubs are associated with increased hand hygiene compliance and are more effective at removing non-spore-forming organisms than are soap and water. 579, 667 However, the use of alcoholbased hand hygiene products after caring for a patient with CDI remains controversial, as alcohol is not sporicidal. Hand washing with soap and water has been shown to be effective at removing Bacillus atrophaeus spores.
668 Presumably, if gloves are worn when caring for a patient with CDI, spores are physically removed during glove removal. In the setting of an outbreak or ongoing C. difficile transmission in an HCT center, the center should consider instructing visitors and HCWs to wash hands with soap and water after contact with patients with CDI or their equipment or environment (BIII). If soap and water are used, proper technique (that is, a minimum 15-30 s of hand washing) should be ensured (BI).
579
C. difficile is primarily transmitted from the hands of HCWs. However, C. difficile can also be acquired from the hospital environment. Currently, there are no approved sporicidal hospital disinfectants. Sodium hypochloritebased cleaning agents (that is, household bleach in water at a 1:10 dilution or at least 5000 p.p.m. available chlorine) are sporicidal within 10 min. 669 One study showed a significant decline in CDI rates in an HCT unit with the use of a bleach-based cleaning agent. 670 The use of bleachcontaining cleaning agents for environmental disinfection should be considered when there is evidence of ongoing C. difficile transmission (BII). The optimal frequency (for example, daily cleaning or cleaning after discharge of the patient from the room) and extent (for example, only rooms of patients with CDI, all patient rooms in the unit or the addition of areas outside patient rooms) of cleaning with bleach-containing agents are unresolved issues.
Recommendations regarding community respiratory virus infections
Hematopoietic cell transplant centers should institute appropriate precautions and infection control measures for preventing the transmission of CRV among hospitalized HCT recipients and candidates undergoing conditioning therapy (AIII). 310, 534, 563, 671 HCT recipients or candidates with URI or lower respiratory infection symptoms due to suspected CRV infection should empirically be placed on contact plus droplet precautions until a specific pathogen has been identified. After identification, precautions should be adjusted on the basis of published guidelines to avoid transmitting infection to other HCT candidates and recipients, as well as to HCWs and visitors (BIII).
144 Pathogen-specific CRV isolation precautions include the following:
Contact precautions for RSV and parainfluenza. Droplet precautions for influenza. Droplet plus contact precautions for adenovirus. Airborne plus contact precautions for primary or disseminated varicella infection.
Personal protective equipment (for example, gown, gloves, surgical mask and eye protection) should be donned before entering and discarded on exiting a patient's room to ensure that personal protective equipment is always changed between patients (AIII).
144
When caring for an HCT recipient or candidate undergoing conditioning therapy with URI or lower respiratory infection, HCWs and visitors should disinfect hands with an alcohol-based gel or, if hands are visibly soiled, with soap and water (AII):
Before and after each contact with a patient. After handling respiratory secretions or fomites potentially contaminated with patients' secretions. Before donning and after removing gloves. 534, 579 Adherence to hand hygiene is critical because most respiratory infections are transmitted by direct contact, particularly by hand to nose and eye. Use of a mask without appropriate hand disinfection, glove-wearing or facial protection is insufficient to prevent transmission of CRV infections. While performing aerosol-generating procedures (for example, bronchoscopy, open suctioning of the respiratory tract (that is, unless in-line suctioning catheters are used), endotracheal intubation), HCWs should wear a face shield that fully covers the front and side of the face, a mask with an attached shield or a mask and goggles, along with gloves and gowns to avoid contamination from the patient's respiratory secretions, regardless of the presence or absence of CRV symptoms (AIII).
Hematopoietic cell transplant centers should consider a daily screening of all persons who enter the center, including HCWs and visitors, for URI symptoms, especially during nosocomial or community outbreaks of CRV infection (Appendix 2) (BIII). HCT center HCWs with URI symptoms should be restricted from patient contact and reassigned to non-patient care duties until symptoms resolve (BII). Visitors with URI symptoms should be asked to defer their visit to the HCT center until their URI symptoms resolve (AII).
298 HCWs and visitors with infectious conjunctivitis should be restricted from direct patient contact until the drainage resolves (AII).
599
Respiratory secretions of any hospitalized HCT candidate or recipient with signs or symptoms of CRV infection should be tested promptly by viral culture or rapid diagnostic tests for CRV (BIII) (see Viral Infections section). Appropriate samples include nasopharyngeal washes, swabs, aspirates (with or without throat swabs) and bronchoalveolar lavage fluid. This practice permits the 309 RSV viral shedding has been reported to last 112 days in a child with SCID. 676 HCT recipients with CRV infection should be placed on appropriate precautions for at least the duration of illness (AII), and precautions should be continued for the duration of hospitalization or viral shedding to prevent transmission within the unit (CIII).
Some HCT centers conduct routine CRV surveillance among asymptomatic HCT recipients to detect outbreaks and implement infection control measures as early as possible. 677 To date, however, data are insufficient to provide recommendations regarding routine surveillance testing of asymptomatic patients for CRV infections. During periods of widespread RSV or influenza activity in the surrounding community or suspected health-careassociated CRV outbreaks, all HCT recipients and candidates with signs or symptoms of respiratory infection should be tested for RSV and influenza infection (that is, for the presence of RSV and/or influenza Ag in respiratory secretions tested by ELISA and viral culture). During an outbreak of health-care-associated RSV infection, managers should cohort health-care personnel as much as is practical (that is, restrict personnel who care for RSVinfected patients from giving care to uninfected patients) (CIII). 297, 298, 678 No recommendation can be made for cohorting of personnel during an outbreak of other health-care-associated CRV infections.
Health-care workers and close contacts of HCT recipients should receive a yearly influenza vaccine at the start of the influenza season, preferably with trivalent inactivated influenza vaccine rather than with live attenuated influenza vaccine to avoid concerns about transmission of vaccine virus (Table 6 ) (AI). Use of influenza vaccine along with prophylaxis and early antiviral therapy among at-risk HCWs and high-risk patients reduces the spread of influenza within health-care facilities.
534 During an outbreak of health-care-associated influenza infection, in addition to the use of droplet precautions for patients with suspected or confirmed influenza and rapid influenza virus testing for symptomatic patients, HCT centers should consider rapid influenza virus testing of symptomatic HCT staff; administration of inactivated influenza vaccine to unvaccinated HCT staff and appropriate patients (see HCT Recipient Vaccinations section); and administration of influenza antiviral chemoprophylaxis to HCT staff and patients according to current recommendations (BIII).
603
Health-care personnel with influenza should be excluded from work for 5 days after the onset of symptoms (AIII). 303, 679 Preventing CRV exposure among HCT recipients after hospital discharge is more challenging because of high CRV prevalence. Preventive measures should be individualized in accordance with the immunological status and tolerance of the patient. In outpatient waiting rooms, patients with CRV infections should be separated to the extent possible from other patients and should be instructed to use respiratory hygiene/cough etiquette (BIII).
Recommendations regarding adenovirus
Adenovirus can cause large outbreaks in hospital settings and chronic care facilities. Outbreaks of diarrheal illness due to adenovirus have been previously described among adult HCT recipients. 680 Transmission can occur through the inhalation of aerosolized droplets; direct and indirect contact through contaminated surfaces; fecal-oral spread; exposure to infected tissue or blood; and, rarely, contaminated water.
330 Sputum or oral secretions of infected adults contain 10 6 -10 7 particles per ml. Non-immune adults can be infected by inhaling as few as five viral particles.
681
Prolonged fecal shedding has been shown in HIV-infected patients with and without diarrhea. Immunocompromised hosts are known to have asymptomatic shedding of adenovirus from the gastrointestinal and respiratory tracts for months after initial infection. Furthermore, immunosuppressed individuals may either reactivate endogenous infection or acquire new infection. Adenovirus survives on non-porous surfaces for up to 35 days. [682] [683] [684] Recommendations for isolation precautions in a hospital setting depend on the type of syndrome caused by adenovirus. HCT recipients with adenoviral gastroenteritis should be placed on contact precautions for at least the duration of illness (AIII), and precautions should be continued for the duration of hospitalization or viral shedding (CIII) to prevent transmission within the unit. For cases of respiratory illness or disseminated infection associated with adenovirus, droplet and contact precautions should be maintained for at least the duration of illness (AIII). 144 For cases of adenoviral conjunctivitis in immunosuppressed patients, contact precautions (AIII) and droplet precautions (CIII) should be instituted for at least the duration of illness (usually 5-7 days) (CIII).
144
Maintaining hand hygiene with either an alcohol-based hand rub or soap and water has been shown to be effective against adenovirus (BIII). 685 Environmental disinfection of surfaces with hospital-approved disinfectants (for example chlorine-based products, ethyl alcohol, ethanol mixed with quaternary ammonium compounds) is important to limit the spread of adenoviral infection.
686
Recommendations regarding viral gastroenteritis Viral gastroenteritis is most commonly spread by the fecaloral route. Common pathogens include rotavirus, norovirus, astrovirus and adenovirus (see the Adenovirus section for adenovirus-specific recommendations). To prevent the acquisition and spread of viral gastroenteritis among HCT recipients, HCT centers should ensure adherence to hand hygiene, appropriate isolation precautions and environmental disinfection (AII).
531 Appropriate precautions should be maintained for at least the duration of illness (AII). As HCT recipients may continue to shed virus after symptoms resolve, HCT centers may choose to continue precautions for the duration of hospitalization, or for the duration of viral shedding if diagnostic laboratory testing is available (CIII). No data regarding safety among HCT recipients. EIII Abbreviation: HCT ¼ hematopoietic cell transplant. a Current Advisory Committee on Immunization Practices (ACIP) and American Academy of Pediatrics guidelines for post-exposure human rabies Ig and vaccine administration should be followed, which include administering five doses of rabies vaccine administered on days 0, 3, 7, 14 and 28 post-exposure.
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Rotavirus
Rotavirus is the most common cause of severe gastroenteritis in infants and young children worldwide. Virus is shed in high concentrations in the stool of infected children and is transmitted primarily by the fecal-oral route, through person-to-person contact and fomites. 687 Environmental contamination is common, as rotavirus can survive on non-porous surfaces for more than 10 days.
688,689 Health-care-associated transmission due to rotavirus infection has been linked to toys 594 and contaminated hands. 690 Contact precautions should be implemented for HCT recipients with suspected or confirmed rotavirus gastroenteritis to prevent transmission in a health-care setting (AIII). Alcohol-based hand gel has some virucidal activity against rotavirus and is sufficient for routine hand hygiene unless hands are visibly soiled. 685 As prolonged shedding can occur in immunocompromised patients, HCT staff should ensure consistent environmental cleaning and disinfection and removal of soiled diapers (AIII). 144 If soiled diapers need to be weighed outside the patient room, it is important to ensure environmental disinfection of items in contact with soiled diapers (for example, cover the scale with paper, appropriately discard soiled diapers and paper and disinfect the scale after each use) (BIII).
Norovirus
Noroviruses are the most common cause of outbreaks of non-bacterial gastroenteritis. Fecal-oral transmission is most common, although environmental and fomite contaminations are also important sources of infection. Aerosolization of vomitus resulting in droplets that contaminate surfaces or are swallowed also contribute to transmission. Infected individuals are contagious up to 72 h after recovery. The low infectious dose (o100 particles), multiple modes of transmission, prolonged duration of viral shedding even among asymptomatic people and the ability to survive high levels of chlorine and varying temperatures (freezing and heating to 60 1C) contribute to the ease of norovirus transmission. Detection of viral RNA in stools by use of reverse transcription PCR assays shows that virus can be isolated as long as 7 days after symptom onset. To reduce the transmission of this highly infectious organism, several strategies need to be used, including hand washing with soap and water, contact precautions, wearing masks while cleaning areas contaminated by feces or vomitus and minimal handling of soiled linens and clothes (BIII). Use of alcohol-based hand rubs may be inadequate for preventing norovirus transmission. [691] [692] [693] Noroviruses are resistant to usual cleaning and disinfection agents.
144 A hypochlorite-based cleaning agent is recommended for use on hard, non-porous environmental surfaces at a concentration of 1000 p.p.m. (1/3 cup bleach in 1 gallon water for 1:50 dilution) to 5000 p.p.m. (1 and 2/3 cup bleach in 1 gallon water for 1:10 dilution), depending on the level of soiling and types of environmental surfaces (BII). 694 In HCT centers without access to prediluted bleach products, staff should prepare a fresh dilution of bleach daily and discard unused portions. Environmental cleaning and disinfection with a hypochlorite-based cleaning agent should be performed at minimum on patient discharge from the room (that is, terminal cleaning) and more frequently as needed (BIII). Quaternary ammonium compounds do not have significant activity because noroviruses are non-enveloped virus particles. Phenolicbased disinfectants are active against noroviruses, but may require concentrations 2-4 times higher than manufacturers' recommendations for routine use. Heat disinfection (pasteurization to 60 1C) has been suggested for items that cannot be cleaned with bleach-based disinfectants.
695
Astroviruses Outbreaks of astrovirus gastroenteritis have occurred in hospitals, nursing homes and daycare centers. [696] [697] [698] Infection can also occur in HCT recipients. 699 Astroviruses can be transmitted through the fecal-oral route, through direct and indirect contact and possibly through contaminated water. 700 Furthermore, virus can persist on fecally contaminated surfaces for several months at relatively low humidity. 531, 689 Contact precautions and environmental disinfection should be used to control the spread of astrovirus infection among HCT recipients during known outbreaks (AII). Quaternary ammonium compounds and chlorine solutions can be effective in inactivating enteric viruses, provided a cleaning step to remove organic matter precedes terminal disinfection.
531
Infection control surveillance
Institutions should follow standard guidelines for surveillance of epidemiologically significant nosocomial pathogens (for example, MRSA, VRE, MDR-GNB, C. difficile, invasive mold infections) and their susceptibility patterns (BIII). 624, 701 In the absence of epidemiological clusters of infections, there is no need to perform routine bacterial surveillance cultures of the HCT center environment, equipment or devices used for respiratory therapy, pulmonary-function testing or delivery of inhalation anesthesia (DIII). 534 Furthermore, in the absence of a nosocomial fungal outbreak, it is not necessary to perform routine fungal cultures of devices or dust (for example, settle plates) in the rooms of HCT recipients and candidates undergoing conditioning therapy (DIII). However, HCT center personnel should perform routine surveillance of cases of invasive mold disease, including aspergillosis, occurring among HCT recipients (BIII). The optimal surveillance definition for nosocomial invasive mold disease is unclear. As HCT recipients have frequent contact with ambulatory healthcare facilities and the incubation period for invasive mold disease is unknown, all cases of invasive mold infection should be tracked regardless of time to onset after admission (BIII). Cases of invasive mold disease with onset of symptoms X7 days after hospital admission are more likely to be hospital acquired. Surveillance definitions can include definitions for proven, probable and possible cases, and criteria can include culture, histology, host factors, indirect tests for detection of fungal Ag or cell-wall constituents and clinical (including radiology) data (BIII). 702 An increase in the number of cases or in the incidence of invasive mold disease among HCT recipients should trigger a careful evaluation of the HCT center environment for sources of mold exposure. In addition, the ventilation system should be evaluated to ensure adequate filtration, air flow and air pressure differentials (see Ventilation section) (BIII). 
